Delivery Order SPE2DB20D3101-SPE2DB24FRAS7
- Not listed
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA). The $1,072.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 10, 2023, with a completion date of March 13, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $102,963.84 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 5, 2023. The contract is a delivery order with a firm fixed price pricing type and a completion date of December 6, 2023. This award is part of a larger, single-award Indefinite Delivery...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $34,644.96 and is a firm fixed-price delivery order, with a completion date of March 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business designation. Amerisourcebergen Drug...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,607.08, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December...
- This federal contract award is for the delivery of Bicillin L-A, a medication with 1,200,000 units in 2ml doses, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $12,967.90, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, with a ceiling value of $1,072.54. The contract has an ultimate completion date of August 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a medication used to treat certain bacterial infections, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $1,175.24 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 29, 2024, with a ceiling value of $2,336.36. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is May 30, 2024. This award is not designated as a set-aside contract....
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic, to the Defense Logistics Agency (DLA). The $102,963.84 Firm Fixed Price contract has an ultimate completion date of August 2, 2023. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, as a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,525.75 and is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm fixed-price, with a completion date of June 17, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRAS7Delivery Order
This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,226.75 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of February 6, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 2/5/24 |